These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 90060)

  • 61. The HLA--B14 cross-reactive group.
    Darke C
    Tissue Antigens; 1980 Apr; 15(4):389-97. PubMed ID: 7466779
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Antigenic determinants of the W28 molecule different from but spatially close to W28 determinant.
    Belvedere M; Richiardi P; Luciani G; Curtoni ES
    Tissue Antigens; 1975 Apr; 5(2):108-19. PubMed ID: 48290
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Structure of crossreactive human histocompatibility antigens HLA-A28 and HLA-A2: possible implications for the generation of HLA polymorphism.
    López de Castro JA; Strominger JL; Strong DM; Orr HT
    Proc Natl Acad Sci U S A; 1982 Jun; 79(12):3813-7. PubMed ID: 6179086
    [TBL] [Abstract][Full Text] [Related]  

  • 64. An immune adsorption technique for analysis of antigenic determinants reacting with HLA antisera.
    Allison JP; Pellegrino MA; Reisfeld RA; Ferrone S
    Transplant Proc; 1977 Dec; 9(4):1691-3. PubMed ID: 74875
    [No Abstract]   [Full Text] [Related]  

  • 65. The molecular basis of HLA cross-reactions: further studies with HLA variants.
    Pious D; Soderland C; Gladstone P
    Transplant Proc; 1977 Mar; 9(1 Suppl 1):39-41. PubMed ID: 67678
    [No Abstract]   [Full Text] [Related]  

  • 66. Five subtypic specificities of the Bw22 complex in four racial groups.
    Danilovs J; Terasaki PI; Gjertson D; Bernoco D
    Transplant Proc; 1978 Dec; 10(4):725-7. PubMed ID: 83705
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Characterization, evolution, and molecular basis of a polymorphic antigenic determinant shared by HLA-A and B products.
    Parham P; McLean J
    Hum Immunol; 1980 Sep; 1(2):131-9. PubMed ID: 6167545
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The detection of two serologically distinct HLA-A28 specificities.
    Holmes DJ; Miller WV; Rodey GE
    Tissue Antigens; 1982 Mar; 19(3):161-7. PubMed ID: 6178180
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Tissue typing of cells in culture. III. HLA antigens of established human cell lines. Attempts at typing by the mixed hemadsorption technique.
    Espmark JA; Ahlqvist-Roth L; Särne L; Persson A
    Tissue Antigens; 1978 Mar; 11(3):279-86. PubMed ID: 77569
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Cross-reacting HLA antigens as a factor increasing the risk of childlessness in a family].
    Montag TS; Drannik GN; Gorpinchenko II; Bystrov LA; Sokolova MN; Vashchenko SN
    Lik Sprava; 1993 Apr; (4):86-90. PubMed ID: 8209461
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Antigen PR - another allele of the HLA-B locus.
    van den Berg-Loonen EM; Siegers H; Milde J; Visser I; Westera A; van Embden E; Englefriet CP
    Tissue Antigens; 1979 Oct; 14(4):343-6. PubMed ID: 94706
    [No Abstract]   [Full Text] [Related]  

  • 72. On the heterogeneity of B40.
    Schreuder I; Nagtegaal-Bos A
    Tissue Antigens; 1979 Jul; 14(1):37-46. PubMed ID: 91218
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Information theory approach to the clustering of serologic reaction patterns.
    Tiwari JL; Park MS
    Transplant Proc; 1978 Dec; 10(4):857-9. PubMed ID: 83721
    [No Abstract]   [Full Text] [Related]  

  • 74. Ia antigens: definition of the HLA-DRw specificities.
    Bodmer JG
    Br Med Bull; 1978 Sep; 34(3):233-40. PubMed ID: 82460
    [No Abstract]   [Full Text] [Related]  

  • 75. [HL-A typing in disease diagnosis].
    Thorsby E
    Tidsskr Nor Laegeforen; 1978 Jul; 98(19-21):961-2. PubMed ID: 80037
    [No Abstract]   [Full Text] [Related]  

  • 76. HLA-A, -B and -C antigens, their serology and cross-reaction.
    Joysey VC; Wolf E
    Br Med Bull; 1978 Sep; 34(3):217-22. PubMed ID: 363218
    [No Abstract]   [Full Text] [Related]  

  • 77. Symbolic reinterpretation of HLA gene products--impact on interpretation of HLA data at the molecular level.
    Wohlgemuth A; Dubey DP
    Comput Appl Biosci; 1987 Sep; 3(3):233-8. PubMed ID: 3453233
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Biological individuality and disease. From Garrod's Chemical Individuality to HLA associated diseases.
    Burgio GR
    Acta Biotheor; 1993 Sep; 41(3):219-30. PubMed ID: 8303967
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The Cusp theory: is there more to HLA-disease association?
    van Drongelen V; Miglioranza Scavuzzi B; Holoshitz J
    Rheumatology (Oxford); 2022 Mar; 61(3):889-891. PubMed ID: 34436565
    [No Abstract]   [Full Text] [Related]  

  • 80. [Serologic methods for determining antigenic characteristics of protein plasma substitutes].
    BOGOMOLOVA LG; ALEKSEEVA AV
    Probl Gematol Pereliv Krovi; 1956; 1(2):52-5. PubMed ID: 13350259
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.